Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction

Persistence of Cardiovascular Risk After Rofecoxib Discontinuation

(2010) Joseph S. Ross   ARCHIVES OF INTERNAL MEDICINE

Increased Mortality and Cardiovascular Morbidity Associated With Use of Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure

(2009) Gunnar H. Gislason et al.   ARCHIVES OF INTERNAL MEDICINE

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

(2009) Rikke Sørensen et al.   LANCET

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

(2008) Tina Ken Schramm et al.   CIRCULATION

Risk of Myocardial Infarction and Death Associated With the Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Among Healthy Individuals: A Nationwide Cohort Study

(2008) EL Fosbøl et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial

(2008) John A Baron et al.   LANCET

Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs

(2008) Tarek A. Hammad et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

(2008) Emil Loldrup Fosbøl et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY